Table 3.
Baseline characteristics of patients underwent endoscopic submucosal dissection and primary surgery for superficial esophageal squamous cell cancer.
Reference | ESD | Surgery | p-value | |
---|---|---|---|---|
Case number | Min et al.,21 Zhang et al.,22 Yamauchi et al.29 Baisi et al.,30 Takeuchi et al.31 | 638 | 546 | |
Age (median) | Min et al.,21 Zhang et al.,22 Baisi et al.,30 Takeuchi et al.31 | 64.1 | 62.6 | 0.136 |
Sex (male %) | Min et al.,21 Zhang et al.,22 Baisi et al.,30 Takeuchi et al.31 | 82.5 | 78.7 | 0.069 |
Lesion size (median, mm) | Min et al.,21 Zhang et al.,22 Baisi et al.,30 Takeuchi et al.31 | 17–45 | 16–52 | 0.163 |
Location | Min et al.,21 Zhang et al.,22 Baisi et al.,30 Takeuchi et al.31 | 0.842 | ||
Upper | 74 | 42 | 0.043* | |
Middle | 332 | 264 | 0.332 | |
Lower | 176 | 189 | 0.687 | |
Invasion depth | Min et al.,21 Zhang et al.,22 Baisi et al.,30 Takeuchi et al.31 | 0.057† | ||
T1a (mucosa) | 425 | 207 | ||
T1b (submucosa) | 159 | 288 | ||
Lesions > 3/4 circumference (%) | Baisi et al.,30 Takeuchi et al.31 | 21.8 | 44.5 | <0.001* |
Lymphovascular invasion (%) | Min et al.,21 Zhang et al.,22 Baisi et al.,30 Takeuchi et al.31 | 7.7 | 15.3 | 0.132† |
Poorly differentiated (%) | Min et al.,21 Baisi et al.,30 | 2.1 | 2.3 | 0.678 |
R0 resection (%) | Zhang et al.,22 Baisi et al.,30 Takeuchi et al.31 | 89.8 | 97.0 | <0.001* |
Recurrence and metastasis (%) | Zhang et al.,22 Baisi et al.,30 Takeuchi et al.31 | 9.4 | 12.2 | 0.646† |
Metachronous recurrence (%) | Min et al.,21 Baisi et al.,30 | 7.4 | 0 | 0.028* |
Procedure time (min, median) | Zhang et al.22 | 53 | 240 | <0.001* |
Hospital stay (days) | Zhang et al.,22 Baisi et al.30 | 4.3 | 12.2 | 0.02* |
p < 0.05.
random-effects model owing to significant heterogeneity.
ESD, endoscopic submucosal dissection.